|
1
|
Bedell AJ: Retinal Vessel Proliferation in
Diabetes. Trans Am Ophthalmol Soc. 43:271–276. 1945.PubMed/NCBI
|
|
2
|
Cholst MR, Levitt LM and Handelsman MB:
Small vessel dysfunction in patients with diabetes mellitus. II.
Retinal vessel response in diabetics following priscoline. Am J Med
Sci. 224:39–41. 1952. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Colwell JA and Lopes-Virella MF: A review
of the development of large-vessel disease in diabetes mellitus. Am
J Med. 85(5A): 113–118. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pedersen J and Olsen S: Small-vessel
disease of the lower extremity in diabetes mellitus. On the
pathogenesis of the foot-lesions in diabetics. Acta Med Scand.
171:551–559. 1962. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kavitha KV, Tiwari S, Purandare VB,
Khedkar S, Bhosale SS and Unnikrishnan AG: Choice of wound care in
diabetic foot ulcer: A practical approach. World J Diabetes.
5:546–556. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Falanga V: Wound healing and its
impairment in the diabetic foot. Lancet. 366:1736–1743. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Walshe TE and D'Amore PA: The role of
hypoxia in vascular injury and repair. Annu Rev Pathol. 3:615–643.
2008. View Article : Google Scholar
|
|
8
|
Cooper ME, Vranes D, Youssef S, Stacker
SA, Cox AJ, Rizkalla B, Casley DJ, Bach LA, Kelly DJ and Gilbert
RE: Increased renal expression of vascular endothelial growth
factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.
Diabetes. 48:2229–2239. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qaum T, Xu Q, Joussen AM, Clemens MW, Qin
W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD
and Adamis AP: VEGF-initiated blood-retinal barrier breakdown in
early diabetes. Invest Ophthalmol Vis Sci. 42:2408–2413.
2001.PubMed/NCBI
|
|
10
|
Advani A, Connelly KA, Advani SL, Thai K,
Zhang Y, Kelly DJ and Gilbert RE: Role of the eNOS-NO system in
regulating the antiproteinuric effects of VEGF receptor 2
inhibition in diabetes. BioMed Res Int. 2013:2014752013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chang Y, Chang TC, Lee JJ, Chang NC, Huang
YK, Choy CS and Jayakumar T: Sanguis draconis, a dragon's blood
resin, attenuates high glucose-induced oxidative stress and
endothelial dysfunction in human umbilical vein endothelial cells.
Scientific-World Journal. 2014:4232592014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu H, Lin S, Xiao D, Zheng X, Gu Y and
Guo S: Evaluation of the Wound Healing Potential of Resina Draconis
(Dracaena cochinchinensis) in Animal Models. Evid Based Complement
Alternat Med. 2013:7098652013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang P, Li J, Tang X, Zhang J, Liang J
and Zeng G: Dracorhodin perchlorate induces apoptosis in primary
fibroblasts from human skin hypertrophic scars via participation of
caspase-3. Eur J Pharmacol. 728:82–92. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu JH, Zheng GB, Liu CY, Zhang LY, Gao HM,
Zhang YH, Dai CY, Huang L, Meng XY, Zhang WY and Yu XF: Dracorhodin
perchlorate induced human breast cancer MCF-7 apoptosis through
mitochondrial pathways. Int J Med Sci. 10:1149–1156. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu Q, Sun E, Xu FJ, Zhang ZH and Jia XB:
Simultaneous content determination of notoginsenoside R1,
ginsenoside Rg1, Re, Rb1 and dracorhodin in ZJHX rubber paste by
double wavelength HPLC. Zhongguo Zhong Yao Za Zhi. 38:2793–2797.
2013.In Chinese.
|
|
16
|
Rasul A, Ding C, Li X, Khan M, Yi F, Ali M
and Ma T: Dracorhodin perchlorate inhibits PI3K/Akt and NF-κB
activation, upregulates the expression of p53, and enhances
apoptosis. Apoptosis. 17:1104–1119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He Y, Ju W, Hao H, Liu Q, Lv L and Zeng F:
Dracorhodin perchlorate suppresses proliferation and induces
apoptosis in human prostate cancer cell line PC-3. J Huazhong Univ
Sci Technolog Med Sci. 31:215–219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xia MY, Wang MW, Cui Z, Tashiro SI,
Onodera S, Minami M and Ikejima T: Dracorhodin perchlorate induces
apoptosis in HL-60 cells. J Asian Nat Prod Res. 8:335–343. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang P, Li J, Tang X, Zhang J, Liang J
and Zeng G: Dracorhodin perchlorate induces apoptosis in primary
fibroblasts from human skin hypertrophic scars via participation of
caspase-3. Eur J Pharmacol. 728:82–92. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roy DC, Mooney NA, Raeman CH, Dalecki D
and Hocking DC: Fibronectin matrix mimetics promote full-thickness
wound repair in diabetic mice. Tissue Eng Part A. 19:2517–2526.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu S, Li Z and Qian G: Quantitative
determination of dracorhodin in Daemonorops draco B1. and
traditional Chinese medicines containing Daemonorops draco B1. by
HPLC. Hua Xi Yi Ke Da Xue Xue Bao. 28:450–453. 1997.In Chinese.
|
|
22
|
Xia M, Wang D, Wang M, Tashiro S, Onodera
S, Minami M and Ikejima T: Dracorhodin perchlorate induces
apoptosis via activation of caspases and generation of reactive
oxygen species. J Pharmacol Sci. 95:273–283. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Corral CJ, Siddiqui A, Wu L, Farrell CL,
Lyons D and Mustoe TA: Vascular endothelial growth factor is more
important than basic fibroblastic growth factor during ischemic
wound healing. Arch Surg. 134:200–205. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kolch W: Meaningful relationships: The
regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.
Biochem J. 351:289–305. 2000. View Article : Google Scholar : PubMed/NCBI
|
